UiO: Life Science invites you to the main event of Oslo Life Science 2019.
The event will highlight inspiring examples on collaboration between academia and industry that have benefitted patients and society. How can we learn from these examples while building the health industry in Oslo and Norway?
Please go to the event-page at UiO:Life Science for more information and registration.
The programme includes:
|The new white paper on health industry
Bent Høie, Minister of Health
|Opening speech by Bayer – the company that bought Algeta, the number one life science success story of the University of Oslo
Kemal Malik, Board of Management of Bayer AG responsible for innovation
|FinnGen – a unique collaboration between academia and industry to find the next breakthroughs in disease prevention, diagnosis and treatment
Aarno Palotie, Research Director, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki; Faculty member, Center for Human Genome Research at the Massachusetts General Hospital; Associate member, Broad Institute of MIT and Harvard
|Innovation and industry collaboration in translational research – lessons learned from Finnish FIMM to inspire the Norwegian NCMM and the life science community in Oslo
Janna Saarela, newly appointed Director of the Centre for Molecular Medicine Norway (NCMM), UiO, who comes from Institute for Molecular Medicine Finland (FIMM)
|Nt-proBNP – the biomarker for heart failure that conquered the world from Oslo
Professor II Christian Hall, University of Oslo and Vestre Viken Hospital Trust; and Mathias Egermark, MD, Senior Vice President, Life Cycle Leader Cardiac, Women’s Health & Personalised Healthcare Solutions, Roche Diagnostics International
|Cutting edge technology for the benefit of patients and society from successful collaboration between the intervention centre at Oslo University Hospital and Siemens
Anne Figel, Director Global Marketing Neurosurgery, Trauma and Orthopedics at Siemens Healthineers
|In addition you will hear from innovative researchers from the University of Oslo and Oslo University Hospital, several of them from UiO:Life Science’s innovation programme SPARK Norway.|
|The main event closes with a debate on lessons learned from the examples we’ve heard and a new era with the new white paper on health industry with leaders from UiO, the pharmaceutical industry, Norway Health Tech and Oslo Cancer Cluster.|
Would you like to register? Please go to the event-page at UiO:Life Science.